BOT:ASX
Botanix Pharmaceuticals Ltd
A$0.010
0.00%
(0.00) 1D
Nov 19, 4:10:03 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
27.63M
Avg. vol.
11.81M
Volume
2.69M
52-wk high
A$0.15
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
27.63M
Avg. vol.
11.81M
Volume
2.69M
52-wk high
A$0.15
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
News stories
From web sources and news partners
ChartMill
·
34 minutes ago
Most-Active S&P 500 Stocks: Ford, Super Micro, Pfizer Lead Session Volume
TradingView
·
2 hours ago
Anthropic Jumps 27% in Record Debut, S&P 500 Eyes Sixth Straight Loss: Stock Market Today
The Motley Fool
·
55 minutes ago
The S&P 500 Is Flashing Warning Signs. Here's Why Long-Term Investors Should Stay the Course.
Traders Union
·
19 minutes ago
Sam Ro: Nvidia nears 25th anniversary of S&P 500 inclusion
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd
CEO-
Employees11
Founded1984
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitebotanixpharma.com